63
Views
18
CrossRef citations to date
0
Altmetric
Review

Bone loss and fractures in multiple sclerosis: focus on epidemiologic and physiopathological features

Pages 505-509 | Published online: 04 Jul 2011

References

  • CompstonAColesAMultiple sclerosisLancet2008251502151718970977
  • RietbergMBBrooksDUitdehaagBMJKwakkelGExercise therapy for multiple sclerosisCochrane Database Syst Rev20051CD00398015674920
  • NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and TherapyOsteoporosis, diagnosis, and therapyJAMA200128578579511176917
  • KruppLBSerafinDJChristodoulouCMultiple sclerosis-associated fatigueExpert Rev Neurother2010101437144720819014
  • AlajbegovicALogaNTiroNDepression in multiple sclerosis patientsMed Arh20116511511821585189
  • SmeltzerSCZimmermanVCapriottiTOsteoporosis risk and low bone mineral density in women with physical disabilitiesArch Phys Med Rehabil20058658258615759248
  • GarlandDEAdkinsRHStewartCARegional osteoporosis in women who have a complete spinal cord injuryJ Bone Joint Surg Am200183A1195120011507128
  • Weinstock-GuttmanBGallagherEBaierMRisk of bone loss in men with multiple sclerosisMult Scler20041017017515124763
  • MarrieRACutterGTyryTA cross-sectional study of bone health in multiple sclerosisNeurology2009731394139819858462
  • WilmetEIsmailAAHeilpornALongitudinal study of bone mineral content and of soft tissue composition after spinal cord injuryParaplegia1995336746778584304
  • ChantraineAActual concept of osteoporosis in paraplegiaParaplegia1978165158733286
  • EliasANGwinupGImmobilization osteoporosis in paraplegiaJ Am Paraplegia Soc1992151631701500942
  • UebelhartDDemiaux-DomenechBRothMBone metabolism in spinal cord injured individuals and in others who have prolonged immobilisation. a reviewParaplegia1995336696738584303
  • TüzünSAltintaşAKaracanIBone status in multiple sclerosis: beyond corticosteroidsMult Scler2003960060414664473
  • BloomfieldSAChanges in musculoskeletal structure and function with prolonged bed restMed Sci Sports Exerc1997291972069044223
  • TakataSYasuiNDisuse osteoporosisJ Med Invest20014814712855 611694954
  • GraboisMPhysical Medicine and Rehabilitation: the Complete ApproachMalden, MABlackwell Science, Inc2000
  • CosmanFNievesJKomarLFracture history and bone loss in patients with MSNeurology199851116111659781548
  • EngelkeKKemmlerWLauberDExercise maintains bone density at spine and hip EFOPS: a 3-year longitudinal study in early postmenopausal womenOsteoporos Int20061713314216096715
  • KraemerWJEndocrine responses and adaptations to strength trainingStrength and Power in SportKomiPVOxfordBlackwell Scientific Publications1992291304
  • PaninNGordayWJPaulBJOsteoporosis in hemiplegiaStroke1971241475112004
  • RamnemarkANybergLLorentzonRHemiosteoporosis after severe stroke, independent of changes in body composition and weightStroke19993075576010187874
  • DionyssiotisYLyritisGPMavrogenisAFFactors influencing bone loss in paraplegiaHippokratia201115545921607037
  • AchironAEdelsteinSZiev-NerYBone strength in multiple sclerosis: cortical midtibial speed-of-sound assessmentMult Scler20041048849315471362
  • NievesJCosmanFHerbertJHigh prevalence of vitamin D deficiency and reduced bone mass in multiple sclerosisNeurology199444168716927936297
  • Van AmerongenBMDijkstraCDLipsPMultiple sclerosis and vitamin D: an updateEur J Clin Nutr2004581095110915054436
  • MahonBDGordonSACruzJCosmanFCantornaMTCytokine prof ile in patients with multiple sclerosis following vitamin D supplementationJ Neuroimmunol200313412813212507780
  • GoldbergPFlemingMCPicardEHMultiple sclerosis: decreased relapse rate through dietary supplementation with calcium, magnesium and vitamin DMed Hypotheses1986211932003537648
  • ZhaoWLiuYCahillCMThe role of T cells in osteoporosis, an updateInt J Clin Exp Pathol20092054455219636401
  • KurbanSAkpinarZMehmetogluIReceptor activator of nuclear factor kappaB ligand (RANKL) and osteoprotegerin levels in multiple sclerosisMult Scler20081443143218208894
  • CanalisEBilezikianJPAngeliAPerspectives on glucocorticoid-induced osteoporosisBone20043459359815050888
  • CanalisEMazziottiGGiustinaAGlucocorticoid-induced osteoporosis: pathophysiology and therapyOsteoporos Int2007181319132817566815
  • LakatosPNagyZKissLPrevention of corticosteroid-induced osteoporosis by alfacalcidolZ Rheumatol200059Suppl 1485210769437
  • MazziottiGAngeliABilezikianJPGlucocorticoid-induced osteoporosis: an updateTrends Endocrinol Metab20061714414916678739
  • SchwidSRGoodmanADPuzasJESporadic corticosteroid pulses and osteoporosis in multiple sclerosisArch Neurol1996537537578759981
  • ShuhaibarMMcKennaMJAu-YeongMFavorable effect of immunomodulator therapy on bone mineral density in multiple sclerosisIr J Med Sci2009178434519002746
  • ManolagasSCCorticosteroids and fractures: a close encounter of the third cell kindJ Bone Miner Res2000151001100510841168
  • PereiraRCDelanyAMCanalisEEffects of cortisol and bone morphogenetic protein-2 on stromal cell differentiation: correlation with CCAAT-enhancer binding protein expressionBone20023068569111996905
  • WeinsteinRSChenJRPowersCCPromotion of osteoclast survival and antagonism of bisphosphonate-induced osteoclast apoptosis by glucocorticoidsJ Clin Invest20021091041104811956241
  • SchwidSRGoodmanADPuzasJESporadic corticosteroid pulses and osteoporosis in multiple sclerosisArch Neurol1996537537578759981
  • De VriesFBrackeMLeufkensHGFracture risk with intermittent high-dose oral glucocorticoid therapyArthritis Rheum20075620821417195223
  • Van StaaTPLeufkensHGAbenhaimLUse of oral corticos-teroids and risk of fracturesJ Bone Miner Res200015993100010841167
  • ZorzonMZivadinovRLocatelliLLong-term effects of intravenous high dose methylprednisolone pulses on bone mineral density in patients with multiple sclerosisEur J Neurol20051255055615958096
  • UranoWFuruyaTInoueEAssociations between methotrexate treatment and methylenetetrahydrofolatereductase gene polymorphisms with incident fractures in Japanese female rheumatoid arthritis patientsJ Bone Miner Metab20092757458319333678
  • AbrahamAKRamanathanMWeinstock-GuttmanBMechanisms of interferon-beta effects on bone homeostasisBiochem Pharmacol2009151757176219428330
  • MurthyJAntiepileptic drugs and bone health: dietary calcium and vitamin D the confounding factorsNeurol India20105817517620508330
  • HaneyEMWardenSJSkeletal effects of serotonin (5-hydroxytryptamine) transporter inhibition: evidence from clinical studiesJ Musculoskelet Neuronal Interact2008813314518622082
  • CattaneoDJonsdottirJZocchiMEffects of balance exercises on people with multiple sclerosis: a pilot studyClin Rehabil20072177178117875557